Physician profile
Lucy Tan
NPI 1275511248
$3,459.10
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $459 · 2021: $740 · 2022: $574 · 2023: $747 · 2024: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $971.15 | 2019-2024 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $689.84 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $440.36 | 2020-2024 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.19 | 2020-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $221.45 | 2022-2023 | |
| Astellas Pharma US INC | $152.37 | 2019-2024 | Veozah |
| Merck Sharp & Dohme LLC | $152.12 | 2019-2022 | |
| Glaxosmithkline, LLC. | $84.73 | 2021-2023 | Trelegy Ellipta |
| Pfizer INC. | $72.78 | 2020-2023 | |
| Amgen INC. | $72.73 | 2019-2021 | |
| Abbvie INC. | $64.33 | 2021 | |
| Amarin Pharma, INC. | $58.45 | 2019-2021 | |
| Genentech USA, INC. | $57.11 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $45.58 | 2019-2023 | |
| Eisai INC. | $29.46 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $28.59 | 2020 | |
| Dexcom, INC. | $26.25 | 2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $16.14 | 2024 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $14.91 | 2021 | |
| Sumitomo Pharma America, INC. | $13.82 | 2024 | Gemtesa |
| Exact Sciences Corporation | $13.17 | 2023 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.